News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,251 Results
Type
Article (49218)
Company Profile (258)
Press Release (689775)
Multimedia
Podcasts (96)
Webinars (13)
Section
Business (215408)
Career Advice (2520)
Deals (36474)
Drug Delivery (112)
Drug Development (83904)
Employer Resources (178)
FDA (16819)
Job Trends (15642)
News (362451)
Policy (34562)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2746)
Academic (1)
Accelerated approval (5)
Adcomms (21)
Allergies (89)
Alliances (53049)
ALS (93)
Alzheimer's disease (1411)
Antibody-drug conjugate (ADC) (128)
Approvals (16813)
Artificial intelligence (267)
Autoimmune disease (23)
Automation (15)
Bankruptcy (367)
Best Places to Work (12034)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (182)
Bladder cancer (65)
Brain cancer (26)
Breast cancer (280)
Cancer (2209)
Cardiovascular disease (179)
Career advice (2114)
Career pathing (32)
CAR-T (151)
Cell therapy (436)
Cervical cancer (20)
Clinical research (67951)
Collaboration (848)
Compensation (527)
Complete response letters (23)
COVID-19 (2730)
CRISPR (40)
C-suite (234)
Cystic fibrosis (102)
Data (2109)
Decentralized trials (2)
Denatured (33)
Depression (46)
Diabetes (267)
Diagnostics (6567)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (127)
Drug pricing (112)
Drug shortages (28)
Duchenne muscular dystrophy (95)
Earnings (90203)
Editorial (42)
Employer branding (23)
Employer resources (153)
Events (118520)
Executive appointments (730)
FDA (18054)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (757)
Gene editing (107)
Generative AI (26)
Gene therapy (312)
GLP-1 (760)
Government (4718)
Grass and pollen (6)
Guidances (51)
Healthcare (19681)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (123)
Indications (28)
Infectious disease (2874)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (94)
Interviews (433)
IPO (16764)
IRA (47)
Job creations (4042)
Job search strategy (1779)
Kidney cancer (10)
Labor market (36)
Layoffs (489)
Leadership (19)
Legal (8600)
Liver cancer (73)
Lung cancer (314)
Lymphoma (147)
Machine learning (5)
Management (61)
Manufacturing (309)
MASH (68)
Medical device (13765)
Medtech (13770)
Mergers & acquisitions (20241)
Metabolic disorders (703)
Multiple sclerosis (80)
NASH (18)
Neurodegenerative disease (93)
Neuropsychiatric disorders (29)
Neuroscience (1953)
NextGen: Class of 2025 (6921)
Non-profit (4800)
Northern California (2598)
Now hiring (38)
Obesity (380)
Opinion (244)
Ovarian cancer (74)
Pain (85)
Pancreatic cancer (82)
Parkinson's disease (149)
Partnered (22)
Patents (233)
Patient recruitment (105)
Peanut (50)
People (60156)
Pharmaceutical (65)
Pharmacy benefit managers (21)
Phase I (21080)
Phase II (29773)
Phase III (22396)
Pipeline (1144)
Policy (152)
Postmarket research (2824)
Preclinical (9092)
Press Release (67)
Prostate cancer (105)
Psychedelics (33)
Radiopharmaceuticals (256)
Rare diseases (395)
Real estate (6293)
Recruiting (67)
Regulatory (23353)
Reports (47)
Research institute (2444)
Resumes & cover letters (412)
Rett syndrome (4)
RNA editing (4)
RSV (45)
Schizophrenia (70)
Series A (132)
Series B (83)
Service/supplier (12)
Sickle cell disease (56)
Southern California (2241)
Special edition (17)
Spinal muscular atrophy (151)
Sponsored (30)
Startups (3764)
State (2)
Stomach cancer (15)
Supply chain (72)
Tariffs (31)
The Weekly (61)
United States (22788)
Vaccines (723)
Venture capitalists (42)
Weight loss (256)
Women's health (36)
Worklife (16)
Date
Today (183)
Last 7 days (535)
Last 30 days (2513)
Last 365 days (33795)
2025 (9949)
2024 (36142)
2023 (40975)
2022 (52259)
2021 (56969)
2020 (55647)
2019 (48619)
2018 (36732)
2017 (33802)
2016 (33721)
2015 (39693)
2014 (33858)
2013 (29338)
2012 (31253)
2011 (31654)
2010 (30086)
Location
Africa (881)
Alabama (55)
Alaska (7)
Arizona (235)
Arkansas (14)
Asia (41165)
Australia (6834)
California (5956)
Canada (1973)
China (519)
Colorado (268)
Connecticut (282)
Delaware (139)
Europe (90787)
Florida (879)
Georgia (206)
Idaho (58)
Illinois (545)
India (26)
Indiana (311)
Iowa (10)
Japan (156)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (64)
Maryland (892)
Massachusetts (4491)
Michigan (226)
Minnesota (384)
Mississippi (2)
Missouri (84)
Montana (27)
Nebraska (26)
Nevada (60)
New Hampshire (66)
New Jersey (1714)
New Mexico (30)
New York (1704)
North Carolina (1007)
North Dakota (7)
Northern California (2598)
Ohio (205)
Oklahoma (15)
Oregon (34)
Pennsylvania (1333)
Puerto Rico (11)
Rhode Island (33)
South America (1267)
South Carolina (21)
South Dakota (1)
Southern California (2241)
Tennessee (102)
Texas (883)
Utah (174)
Virginia (146)
Washington D.C. (63)
Washington State (544)
West Virginia (3)
Wisconsin (52)
739,251 Results for "john wiley and sons inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MindMed Appoints Matt Wiley as Chief Commercial Officer
March 17, 2025
·
7 min read
Press Releases
Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University
March 7, 2025
·
4 min read
Press Releases
Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors
March 5, 2025
·
4 min read
Press Releases
Wiley Announces Quarterly Dividend
December 12, 2024
·
1 min read
Press Releases
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
April 17, 2025
·
2 min read
Press Releases
Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
April 8, 2025
·
4 min read
Press Releases
Marius Pharmaceuticals Welcomes John “Shrek” Mcphee as Kyzatrex® (testosterone undecanoate) CIII Capsules Patient Ambassador
April 22, 2025
·
7 min read
Drug Development
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that the safety of SON-1010 dosing has been formally reviewed in both of the current Phase 1 clinical trials and the Company is now increasing the target dose of SON-1010 during dose escalation.
May 20, 2024
·
11 min read
Business
Wiley Hosts Investor Update
Wiley (NYSE: WLY and WLYB), one of the world’s largest publishers and a global leader in research and learning, will host its Investor Update today at 10 am E.T. to discuss the company’s business and financial outlook.
January 25, 2024
·
5 min read
Press Releases
Crown Bioscience Appoints John Gu as Chief Executive Officer
March 13, 2025
·
3 min read
1 of 73,926
Next
